{
    "Overall_score": {
        "Correlation": 9,
        "Sentiment": 4,
        "Importance": 8,
        "Impact": 7,
        "Duration": 6,
        "Virality": 3,
        "Source_Score": 5,
        "Specificity": 10,
        "Sector_Spread": 7,
        "Tech_Mentions": 8
    },
    "Each_item": [
        {
            "News_content": "RT @jq1234t: $SNY discontinued further development of SAR3419 (CD19 ADC) in ALL, SAR339658 (anti-VLA 2 mAb) in UC - initiate ph2 in MS inst",
            "Correlation": 9,
            "Sentiment": 4,
            "Importance": 8,
            "Impact": 7,
            "Duration": 6,
            "Virality": 3,
            "Source_Score": 5,
            "Specificity": 10,
            "Sector_Spread": 7,
            "Tech_Mentions": 8
        }
    ]
}